EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic Innovations

Joshua H Liu iD, Maksym Horiachok, Santosh Guru, Cecile L Maire iD

Brain Sciences · 02.08.2025 · 15 (8) · 833

DOI: 10.3390/brainsci15080833 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 02.08.2025. Verfasst von Joshua H Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains one of the most aggressive and treatment-resistant brain tumors, largely due to its profound intratumoral heterogeneity and immunosuppressive microenvironment. Various classifications of GBM subtypes were created based on transcriptional and methylation profiles. This effort, followed by the development of new technology such as single-nuclei sequencing (snRNAseq) and spatial transcriptomics, led to a better understanding of the glioma cells’ plasticity and their ability to transition between diverse cellular states. GBM cells can mimic neurodevelopmental programs to resemble oligodendrocyte or neural progenitor behavior and hitchhike the local neuronal network to support their growth. The tumor microenvironment, especially under hypoxic conditions, drives the tumor cell clonal selection, which then reshapes the immune cells’ functions. These adaptations contribute to immune evasion by progressively disabling T cell and myeloid cell functions, ultimately establishing a highly immunosuppressive tumor milieu. This complex and metabolically constrained environment poses a major barrier to effective antitumor immunity and limits the success of conventional therapies. Understanding the dynamic interactions between glioma cells and their microenvironment is essential for the development of more effective immunotherapies and rational combination strategies aimed at overcoming resistance and improving patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

T cell exhaustionglioblastomaheterogeneityimmunosuppression

Autor:innen und Institutionen

  • Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Medical Faculty, Bukovinian State Medical University, 58002 Chernivtsi, Ukraine.
  • School of Clinical Medicine, University of Cambridge, Cambridge CB2 1TN, UK.
  • Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

ORCID-Profile: Joshua H Liu, Cecile L Maire

Zitieren

APA

Liu, J. H., Horiachok, M., Guru, S., & Maire, C. L. (2025). Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic Innovations. Brain Sciences, 15(8), 833. https://doi.org/10.3390/brainsci15080833

Vancouver

Liu JH, Horiachok M, Guru S, Maire CL. Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic Innovations. Brain Sciences. 2025;15(8):833. doi:10.3390/brainsci15080833

BibTeX
@article{Liu2025,
  author = {Liu, Joshua H and Horiachok, Maksym and Guru, Santosh and Maire, Cecile L},
  title = {Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic Innovations},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {8},
  pages = {833},
  doi = {10.3390/brainsci15080833}
}
Kostenlos starten →